New World Medical Company Profile

Sr. No.

Item

Description

1

Company Name

New World Medical

2

Website

www.newworldmedical.com

3

Established Date

1990

4

Headquartered

California, United States

5

Market Position/ History

N Dr. A. Mateen Ahmed founded New World Medical and introduced the Ahmed Glaucoma Valve to the world. The company’s flagship products are supported by a robust network of surgical sales consultants in the U.S. and an exclusive distribution network internationally.

6

Sales Area

Worldwide

7

Manufacturing Location

California, United States

8

No. of Employees

Over 200 employees

9

Competitors

• Alcon Inc
• AbbVie Inc
• Johnson & Johnson Vision Care, Inc
• ISTAR MEDICAL SA.
• BVI Medical, Inc.

10

CEO

Bilal Khan

11

Ownership Type

Private

12

Contact Information

10763 Edison Court, Rancho Cucamonga, CA 91730, United States

Tel: (909) 466-4304

Product

Product Description

Ahmed Glaucoma Valve

The Ahmed Glaucoma Valve is a leading device in the treatment of refractory glaucoma, designed to provide immediate and effective intraocular pressure (IOP) reduction. It is particularly useful for patients with glaucoma that have not responded to conventional treatments.

Key Features:

1. Immediate IOP Reduction: The Ahmed Glaucoma Valve delivers prompt and reliable control of intraocular pressure through its innovative flow restrictor mechanism.
2. Controlled Flow: The unique valve system within the device regulates fluid flow, minimizing the risk of excessive drainage and chamber collapse, which can lead to hypotony (abnormally low pressure within the eye).
3. Preventing Hypotony: The elastic membranes in the valve adjust their shape to maintain consistent fluid flow and adjust the tension to mitigate the risk of hypotony.
4. Design and Material: The valve features a tapered profile for ease of insertion and is constructed from medical-grade silicon. This design helps facilitate the implantation process and enhances patient comfort.

Technical Specifications:

• Material: Medical-grade silicon.
• Valve System: Features a flow restrictor and elastic membranes for controlled fluid regulation.
• Profile: Tapered design for easier insertion.

Reimbursement Information:

1. Glaucoma Shunt Surgery (Without Patch Graft):
   • CPT Code: 66179
   • Description: Aqueous Shunt to Extraocular Reservoir, Without Patch Graft.
2. Glaucoma Shunt Surgery (With Patch Graft):
   • CPT Code: 66180
   • Description: Aqueous Shunt to Extraocular Reservoir, With Patch Graft.

Ahmed ClearPath

The Ahmed ClearPath is an advanced valveless drainage device designed to address the needs of patients with refractory glaucoma. It combines innovative features with a flexible design to enhance surgical convenience and effectiveness.

Key Features:

1. Valveless Design:
   • Eliminates Flow Restrictor: Unlike traditional valved devices, the ClearPath features a valveless design that simplifies the drainage process by removing the flow restrictor component.
2. Size Options:
   • 250 mm² Model: The ClearPath 250 is a true single-quadrant device, positioned between muscles without the need for muscle isolation.
   • 350 mm² Model: The ClearPath 350 offers a larger plate surface and is designed to avoid muscle attachment points, providing broader coverage and reducing the risk of complications associated with muscle interference.
3. Flexible and Conformable:
   • Material: Both models are made from a flexible material that conforms to the shape of the eye, ensuring a better fit and enhanced patient comfort.
   • Design: The devices are designed to fit the globe of the eye more naturally, accommodating various anatomical configurations.
4. Ease of Implantation:
   • Anteriorly Placed Suture Points: Both the 250 and 350 models feature anteriorly placed suture points, facilitating easier access and implantation during surgery.
5. Needle and Ripcord:
   • Included Components: The device includes a 23-Ga needle for implantation and a threaded 4-0 polypropylene ripcord, which aids in the precise positioning and fixation of the device.

Reimbursement Information:

1. Glaucoma Shunt Surgery (Without Patch Graft):
   • CPT Code: 66179
   • Description: Aqueous Shunt to Extraocular Reservoir, Without Patch Graft.
2. Glaucoma Shunt Surgery (With Patch Graft):
   • CPT Code: 66180
   • Description: Aqueous Shunt to Extraocular Reservoir, With Patch Graft.

KDB GLIDE

The KDB GLIDE is a precision tool designed for excisional goniotomy, featuring innovative elements for smooth, effective procedures.

Key Features:

• Ramp & Dual Blades: The ramp assists in lifting and stretching the trabecular meshwork (TM), while dual blades ensure clean, parallel incisions for effective TM excision.
• Tapered Sides & Footplate: Facilitates a precise fit with the canal of Schlemm, accommodating varying anatomical configurations.
• Rounded Heel: Provides a seamless transition through the canal of Schlemm, enhancing the accuracy of the excisional goniotomy.

Benefits:

• Precision Design: Optimized for precise excision of diseased TM, improving access to collector channels.
• Proven Technique: Supports a well-established, implant-free method requiring only 90-120 degrees of treatment.
• Cost-Effective: Designed to be economical for both facilities and patients.

Reimbursement:

The KDB GLIDE supports excisional goniotomy under established CPT I codes, ensuring a straightforward reimbursement process.

Year

Latest News

May 22, 2024

New World Medical Receives 510(k) Clearance for Expanded KDB GLIDE Indication

New World Medical announced FDA 510(k) clearance for the KDB GLIDE device, now indicated for reducing intraocular pressure (IOP) in adults with primary open-angle glaucoma (POAG) during cataract surgery or as a stand-alone procedure. This expansion is based on extensive data demonstrating the device’s efficacy in lowering IOP by ≥20% on average.